Beyond Data Packages: Derisking Tech Transfer To CDMOs

Technology transfer to a CDMO is rarely as simple as handing over a data package. From documentation gaps and equipment differences to method variability and global standards, many programs encounter avoidable risks that can derail timelines and increase cost. In this Outsourced Pharma Live session, industry experts share practical strategies to help sponsors better prepare for tech transfer and align more effectively with CDMO partners.

Join us to learn how tools like smarter documentation systems, design of experiments, and in silico modeling can support stronger CMC alignment and improve the likelihood of a right-first-time transfer—across small molecules, biologics, and advanced therapies.